title: Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
authors.affiliation: Department of Nursing, California State University, Fresno, California, USA.
authors.forename: Debbie
authors.initials: D
authors.lastname: Steele
authors.forename: Norman L
authors.initials: NL
authors.lastname: Keltner
authors.forename: Teena M
authors.initials: TM
authors.lastname: McGuiness
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D003987:Dibenzothiazepines / Q000009:adverse effects; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives; D008875:Middle Aged; D000078785:Mirtazapine; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000503:physiopathology*; D000069348:Quetiapine Fumarate; D012307:Risk Factors; D020230:Serotonin Syndrome / Q000175:diagnosis / Q000503:physiopathology*
chemical_list: D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D008803:Mianserin; D000069348:Quetiapine Fumarate; D000078785:Mirtazapine; D006220:Haloperidol